| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $311.7M | +617.0% |
| Cost of Revenue | $22.1M | +592.3% |
| Gross Profit | $275.7M | +584.6% |
| R&D Expense | $19.3M | +390.4% |
| SG&A Expense | $68.2M | +127.7% |
| Operating Income | $150.1M | +771.6% |
| Pre-tax Income | $150.0M | +876.3% |
| Income Tax | -$13.0M | -834.8% |
| Net Income | $163.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.8M | +256.3% |
| Short-term Investments | $3.7M | -66.5% |
| Accounts Receivable | $171.2M | +231.5% |
| Inventory | $29.7M | +291.0% |
| Current Assets | $367.1M | +220.4% |
| Total Assets | $826.1M | +595.1% |
| Current Liabilities | $174.3M | +415.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $175.0M | +445.8% |
| Capital Expenditures | $2.3M | +1852.8% |
| Investing Cash Flow | -$308.4M | -1552.8% |
| Financing Cash Flow | $238.5M | +806.0% |
| Free Cash Flow | $172.8M | +440.6% |
| +1009.4% |
| EPS (Basic) | $2.25 | +850.0% |
| EPS (Diluted) | $2.04 | +780.0% |
| Total Liabilities |
| $420.8M |
| +1130.9% |
| Stockholders' Equity | $405.3M | +378.8% |